Most importantly, our findings reveal an inhibitory role of GITR in regulating NF-κB pathway, providing a novel insight into the role of TNFRSFs family in MM pathogenesis and disease progression, thus supporting the therapeutic use of NF-κB inhibitors in MM patients who present with increased GITR methylation. Here, TNFRSF18 is linked to Miyoshi myopathy.